GH Research (GHRS) Shareholder's Equity (2021 - 2025)
GH Research (GHRS) Shareholder's Equity (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
502.95 Mn |
| 10 |
GH Research |
9.73 Bn |
9.63 Bn |
- |
279.70 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
279.70 Mn |
| Sep 30, 2025 |
291.40 Mn |
| Jun 30, 2025 |
303.18 Mn |
| Mar 31, 2025 |
310.21 Mn |
| Dec 31, 2024 |
178.95 Mn |
| Sep 30, 2024 |
189.37 Mn |
| Jun 30, 2024 |
198.68 Mn |
| Mar 31, 2024 |
209.75 Mn |
| Dec 31, 2023 |
218.97 Mn |
| Sep 30, 2023 |
225.77 Mn |
| Jun 30, 2023 |
232.98 Mn |
| Mar 31, 2023 |
241.83 Mn |
| Dec 31, 2022 |
249.82 Mn |
| Sep 30, 2022 |
256.74 Mn |
| Jun 30, 2022 |
263.22 Mn |
| Mar 31, 2022 |
269.48 Mn |
| Dec 31, 2021 |
277.18 Mn |
| Sep 30, 2021 |
283.60 Mn |
